Mega Lifesciences PCL (BKK:MEGA)
Thailand flag Thailand · Delayed Price · Currency is THB
35.00
0.00 (0.00%)
Sep 3, 2026, 4:36 PM ICT

Mega Lifesciences PCL Stock Forecast

Stock Price Forecast

According to 7 analysts polled by S&P Global, Mega Lifesciences PCL stock has a consensus rating of "Buy" and an average price target of ฿42.71. The average 1-year stock price forecast is 22.03% higher than the current stock price, while the lowest is ฿35.00 (0.00%) and the highest is ฿45.00 (+28.57%).

Price Target: ฿42.71 (+22.03%)
Analyst Consensus: Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price฿35.00฿42.71฿44.00฿45.00
Change0.00%+22.03%+25.71%+28.57%

Analyst Ratings

The average analyst rating for Mega Lifesciences PCL stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Chart
RatingMar '26Apr '26May '26Jun '26Jul '26Aug '26
Strong Buy555555
Buy000001
Hold001110
Sell111111
Strong Sell000000
Total667777

Financial Forecast

Revenue This Year
14.35B
from 14.19B
Increased by 1.07%
Revenue Next Year
15.66B
from 14.35B
Increased by 9.18%
EPS This Year
2.54
from 2.34
Increased by 8.33%
EPS Next Year
2.85
from 2.54
Increased by 12.56%
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
14.17B15.73B15.72B15.39B14.19B14.35B
Revenue Growth
12.36%10.97%-0.07%-2.10%-7.74%1.07%
Gross Profit
5.95B7.08B7.13B7.80B7.43B7.38B
Gross Margin
41.97%45.02%45.37%50.67%52.35%51.45%
Operating Income
2.18B2.72B2.94B3.41B2.95B2.75B
Net Income
1.95B2.24B1.99B2.01B1.91B2.23B
EPS
----2.342.54
EPS Growth
----1.30%8.33%
Forward PE
22.8517.7614.5211.2913.0713.81
Dividend / Share
1.381.601.601.601.601.76
Dividend Growth
53.33%15.94%---10.00%
Free Cash Flow
1.99B1.21B1.41B2.29B2.08B2.06B
No. Analysts
-----2
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is THB.

Revenue Forecast

Revenue202620272028
High14.4B
Avg14.3B
Low14.3B

Revenue Growth

Revenue Growth202620272028
High
1.5%
Avg
1.1%
Low
0.7%

EPS Forecast

EPS202620272028
High2.63
Avg2.54
Low2.43

EPS Growth

EPS Growth202620272028
High
12.4%
Avg
8.3%
Low
3.8%